| |
 |
|
Class Information
Number: 514/54
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Carbohydrate (i.e., saccharide radical containing) doai > Polysaccharide
Description: Subject matter wherein the organic active ingredient contains more than two saccharide radicals directly or indirectly bonded together.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6497863 |
Deodorizing preparations |
Dec. 24, 2002 |
| 6497865 |
Cosmetic hair care preparations |
Dec. 24, 2002 |
| 6495147 |
Uses of D-xylose, the esters thereof and oligosaccharides containing xylose for improving the functionality of epidermal cells |
Dec. 17, 2002 |
| 6495148 |
Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions |
Dec. 17, 2002 |
| 6495608 |
Methods of performing surgery with galactomannan polymers and borate |
Dec. 17, 2002 |
| 6492337 |
Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complication |
Dec. 10, 2002 |
| 6492349 |
Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
Dec. 10, 2002 |
| 6488955 |
Nutrient composition for exercise |
Dec. 3, 2002 |
| 6489302 |
Saccharide conjugates |
Dec. 3, 2002 |
| 6489309 |
Polysaccharide conjugates of biomolecules |
Dec. 3, 2002 |
| 6489310 |
Fiber blend for enteral composition |
Dec. 3, 2002 |
| 6486137 |
Oligosaccharide mixtures having antithrombotic activity |
Nov. 26, 2002 |
| 6486138 |
Ophthalmic compositions containing galactomannan polymers and borate |
Nov. 26, 2002 |
| 6486139 |
Ophthalmic solution comprising glycogen |
Nov. 26, 2002 |
| 6486215 |
Solutions for treating contact lenses |
Nov. 26, 2002 |
| 6482806 |
Product of heat treatment of uronic acid, food, drink, or drug including the product |
Nov. 19, 2002 |
| 6482807 |
LPS with reduced toxicity from genetically modified gram negative bacteria |
Nov. 19, 2002 |
| 6482401 |
Composition for the relief of joint pain and myofascial pain and method of preparing same |
Nov. 19, 2002 |
| 6475468 |
Modulated release particles for aerosol delivery |
Nov. 5, 2002 |
| 6475512 |
Process for improving glucose metabolism, satiety, and nutrient absorption in companion animals |
Nov. 5, 2002 |
| 6475520 |
Pharmaceutical composition with low toxicity for anti-inflammation and anti-exudation |
Nov. 5, 2002 |
| 6476001 |
Facilitation of repair of neural injury with CM101/GBS toxin |
Nov. 5, 2002 |
| 6476002 |
Treatment of chronic inflammatory diseases with CM101/GBS toxin |
Nov. 5, 2002 |
| 6476003 |
Method for preparing small particle size glucan in a dry material |
Nov. 5, 2002 |
| 6476005 |
Oral and injectable nutritional composition |
Nov. 5, 2002 |
| 6472379 |
Angiogenesis inhibition |
Oct. 29, 2002 |
| 6468964 |
Control of acidic gut syndrome |
Oct. 22, 2002 |
| 6468987 |
Nutritional product for a person having ulcerative colitis |
Oct. 22, 2002 |
| 6468989 |
Gel compositions containing metronidazole |
Oct. 22, 2002 |
| 6464970 |
Method and composition for preventing surgical adhesions |
Oct. 15, 2002 |
| 6464981 |
Therapeutic agent for a cancer and method of screening the same, and health-care auxiliary food |
Oct. 15, 2002 |
| 6465434 |
Methods and compositions for the inhibition of cancer metastasis mediated by endothelial adhesion molecules |
Oct. 15, 2002 |
| 6465435 |
Treatment of C. difficile toxin B associated conditions |
Oct. 15, 2002 |
| 6462029 |
Compositions and methods for treating mammals with modified alginates and modified pectins |
Oct. 8, 2002 |
| RE37872 |
Storage of materials |
Oct. 8, 2002 |
| 6458774 |
Compositions containing hyaluronic acid associates and a process for preparing same |
Oct. 1, 2002 |
| 6455068 |
Dietary fiber delivery system |
Sep. 24, 2002 |
| 6455511 |
Compositions for use in rehydration and nutrition during athletic exercise and methods of making same |
Sep. 24, 2002 |
| 6455512 |
Water-soluble esterified hydrocolloids |
Sep. 24, 2002 |
| 6451766 |
Neuraminic acid derivatives, their preparation and their medical use |
Sep. 17, 2002 |
| 6451771 |
Use of anabolic agents anti-catabolic agents and antioxidant agents for protection treatment and repair of connective tissues in humans and animals |
Sep. 17, 2002 |
| 6451772 |
Biopolymer salts with low endotoxin levels, biopolymer compositions thereof and methods of making the same |
Sep. 17, 2002 |
| 6447812 |
Chemical composition for aiding the absorption, binding and elimination of undigested fat |
Sep. 10, 2002 |
| 6444448 |
Production of .beta.-glucan-mannan preparations by autolysis of cells under certain pH, temperature and time conditions |
Sep. 3, 2002 |
| 6444653 |
Glass-like polysaccharide useful as absorbent for liquids |
Sep. 3, 2002 |
| 6444654 |
Isolated asgal lipopolysaccharides and use of same to inhibit innate immune response |
Sep. 3, 2002 |
| 6444655 |
Galactopyranosides and their use |
Sep. 3, 2002 |
| 6444700 |
Product and method to reduce stress induced immune suppression |
Sep. 3, 2002 |
| 6440427 |
Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer |
Aug. 27, 2002 |
| 6440934 |
Angiogenically effective unit dose of FGF-2 and method of use |
Aug. 27, 2002 |
|
|
|
